Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Heijman, J; Voigt, N; Carlsson, LG; Dobrev, D.
Cardiac safety assays
CURR OPIN PHARMACOL. 2014; 15: 16-21. Doi: 10.1016/j.coph.2013.11.004
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz

Heijman Jordi

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Cardiac safety, including the risk of drug-induced `torsades de pointes' (TdP) arrhythmia, is a major concern in the development, approval and prescription of new drugs. Assessment of surrogate markers of TdP-risk, such as QTinterval prolongation or inhibition of the rapid delayed-rectifier K+-current ('Kr) encoded by the human ether-a-go-go-related gene (hERG), is therefore required before drug approval. Here, we review some methodologies employed to assess proarrhythmia liability of drugs, discuss the challenges involved in this process, and highlight promising novel cardiac-safety assays.

© Med Uni Graz • Imprint